Group A: Patient Data and Scintigraphic Results
| Patient no. | Year of birth | Sex | Stage of disease | Duration of disease (mo) | No. of pretherapies | MIBI findings | V-DMSA findings |
|---|---|---|---|---|---|---|---|
| 1 | 1961 | F | III | 21 | 3 | F + D | + |
| 2 | 1946 | M | III | 60 | 6 | F + D | + |
| 3 | 1924 | M | III | 2 | 1 | D | − |
| 4 | 1933 | F | III | 1 | 1 | D | − |
| 5 | 1933 | M | III | 39 | 4 | D | + |
| 6 | 1924 | F | III | 59 | 3 | D | + |
| 7 | 1951 | F | III | 2 | 1 | F | + |
| 8 | 1947 | M | III | 1 | 1 | F | − |
| 9 | 1935 | M | III | 41 | 6 | F + D | + |
| 10 | 1933 | M | III | 58 | 3 | F | + |
| 11 | 1935 | F | III | 16 | 2 | F | + |
MIBI findings: F = areas of focal uptake of tracer; D = diffuse bone marrow uptake.
V-DMSA findings: + = at least 1 lesion with increased V-DMSA activity; − = no V-DMSA activity.
All patients in group A were receiving chemotherapy.